about
HPV Associated Head and Neck CancerMicro-RNAs as diagnostic or prognostic markers in human epithelial malignanciesPotential use of cetrimonium bromide as an apoptosis-promoting anticancer agent for head and neck cancerMiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathwayA porphodimethene chemical inhibitor of uroporphyrinogen decarboxylasePhotoacoustic radar phase-filtered spatial resolution and co-registered ultrasound image enhancement for tumor detection.Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands.Hemochromatosis enhances tumor progression via upregulation of intracellular iron in head and neck cancer.Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent.Nasopharyngeal cancer: new frontiers from the laboratory to the clinic.Imaging and modulating antisense microdistribution in solid human xenograft tumor models.Increased efficiency for performing colony formation assays in 96-well plates: novel applications to combination therapies and high-throughput screening.Carcinoma of the maxillary antrum: a retrospective analysis of 110 cases.Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.MicroRNA-301 mediates proliferation and invasion in human breast cancer.Identification of a recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma.NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data.Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries.MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1.Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98.MicroRNAs in nasopharyngeal carcinoma.Integrated omic analysis of oropharyngeal carcinomas reveals human papillomavirus (HPV)-dependent regulation of the activator protein 1 (AP-1) pathway.MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer.Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues.Novel gene therapy approach for nasopharyngeal carcinoma.Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy.Pre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma.Developing a prognostic micro-RNA signature for human cervical carcinoma.Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.Spinal cord stimulators and radiotherapy: first case report and practice guidelinesChromosomal instability as a prognostic marker in cervical cancer.The potential role of breast conservation surgery and adjuvant breast radiation for adenoid cystic carcinoma of the breast.Redirecting tyrosine kinase signaling to an apoptotic caspase pathway through chimeric adaptor proteins.Quantitative phase-filtered wavelength-modulated differential photoacoustic radar tumor hypoxia imaging toward early cancer detection.Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.A spectrum of basaloid morphology in a subset of EBV-associated "lymphoepithelial carcinomas" of major salivary glands.Prognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomasMiR-449a promotes breast cancer progression by targeting CRIP2.The complexity of microRNAs in human cancer.
P50
Q26741386-323297DE-7C14-4B1B-9853-395254C8F81CQ26823077-1EA80270-B1AD-4A3D-988D-6B2158D4F027Q28253855-A3A5E642-DBFB-422F-BE97-CB63FD72268EQ28306813-0F2EF458-E569-4A12-9654-B7AED46CA11CQ28540127-6693154F-5A03-423C-8AD5-4FAF693A71BFQ30416361-7E93DEBA-07DE-41DE-8767-25160C2592FBQ30459163-08A63789-FAC6-4717-9822-758D8457F831Q31133925-4BFC7540-0AF6-45FE-B999-E7EAD55F358AQ33258085-20A6220E-9DD1-4976-A1E3-9381660F57B6Q33298559-AB0C1A5D-5C4C-47BA-A818-F7A741C6E975Q33301099-4A55DD27-BD5F-4D41-A4A5-95AA2EC4180AQ33329198-5417473E-7432-47E2-BD8F-785DF051697AQ34071806-9860C1A2-D0D7-4945-B41E-0B9342661BDAQ34097908-01547E18-F377-4E37-BFFE-51478B51DFDAQ34169881-83DCC2D1-7E62-4622-80C9-9068BBE62415Q34200710-64402EB0-28DF-4ED7-AB38-6A487CD926C9Q34238131-F718367C-6C16-4D93-BB80-32C92D00A1C4Q34538489-82F2B228-2373-41AB-AE18-35470FD102FFQ34540605-3DB001B1-F767-4A7A-A7AC-8CA810D20FDBQ34555750-94219D42-45ED-4C50-8E8A-99E5907BFB31Q34561758-C9ED579C-9E7C-4A60-B9F1-15E823B76ACDQ34572800-64BE7843-7B2A-49AE-9A1F-7B0D075B65B2Q34635004-6147F062-4530-45FF-8B64-2E996529CF73Q34826310-2AA2008F-7B28-4CE1-B35F-25AB259ABF7EQ34963516-6CC64648-7CC0-458C-AA52-9918D9AF5B4FQ35008899-7D7F3758-C415-4C64-8755-F29EFDAAB4F6Q35093740-A49EBA7E-BD19-497A-B42E-CF337C2A1490Q35172674-22B71C83-DF11-447A-82F5-7D5BE5D685A7Q35447762-EF15B3B5-63A0-4C67-9F51-348DF505306CQ35558660-78610A9B-403A-4066-A7C7-ACE37B48DC46Q35602740-E5020816-A57A-425E-9B03-C8348CC24B8AQ35610374-ABC43A7D-C9E2-4EDB-BECE-58CE7A457FC1Q35940712-BCD22F63-C32A-4E01-838C-5146C29E4AECQ36160642-8F42BFB5-6B33-4221-802D-F1CBB4C5CC7FQ36167333-C8EC604B-5E37-4D70-877E-C86C38E9943BQ36386860-168E6EF2-2D2A-4CF8-9154-50295C65DAA2Q36407415-2D7C3022-6839-4736-817E-5408DB7AE8D9Q36629530-59BC6230-E781-483A-81FF-FAF1186C7867Q37109894-323290A1-EF28-4194-BF94-0F0F86E31181Q37187237-BFF4F5B1-968B-46CC-BA60-F76AD6FF0E76
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fei-Fei Liu
@ast
Fei-Fei Liu
@en
Fei-Fei Liu
@es
Fei-Fei Liu
@sl
type
label
Fei-Fei Liu
@ast
Fei-Fei Liu
@en
Fei-Fei Liu
@es
Fei-Fei Liu
@sl
prefLabel
Fei-Fei Liu
@ast
Fei-Fei Liu
@en
Fei-Fei Liu
@es
Fei-Fei Liu
@sl
P108
P106
P1153
36067802500
P21
P31
P496
0000-0003-4344-6486